Media Coverage header image

Media Coverage

Advanced Search
  • 07182019
    KXTQ-FM Online

    Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of major diagnostic laboratories collaborating to generate enhanced diagnostics insights to improve the delivery of global healthcare. Regional companies LSI Medience, and Strand Life Sciences join Quest and the charter members -- Al Borg Medical Laboratories, Dasa, GC Labs, Healius, KingMed Diagnostics, SYNLAB – as GDN members.

  • 07172019
    360Dx

    Quest Diagnostics said today it has entered an agreement to provide Catholic Health Services of Long Island with laboratory management services and reference testing.[CR-LF][CR-LF]Under the agreement, Quest will provide CHS with lab testing as well as management of lab equipment, supplies, and procurement processes. The agreement covers six CHS hospitals, a core lab, a cancer center, and an infusion center.

  • 07122019
    360Dx

    Digital health firm Sharecare said today that it is collaborating with Quest Diagnostics on tools for digital health management.[CR-LF][CR-LF]As part of the collaboration, Quest has made a strategic investment of an undisclosed amount in Sharecare, which named Quest its preferred laboratory partner. The development of disease management programs and other services will also be explored, they said.

  • 07112019
    RevCycle Intelligence

    HHS recently announced the creation of the Quality Summit, which will bring together federal and private healthcare stakeholders to evaluate and streamline federal value-based care programs.[CR-LF][CR-LF]The summit is in response to the Trump Administration’s recent executive order calling for greater healthcare price and quality transparency. Physicians in a 2018 report from Quest Diagnostics also called for less complex quality measurement.

  • 07092019
    Outdoor Sportswire Online

    Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today launched a new Lyme Disease test offering that individuals can purchase through Quest’s consumer-initiated testing service, QuestDirect.[CR-LF][CR-LF]The blood test screens for immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies produced by the body to fight infection to the bacterium that causes Lyme disease. Through this service, individuals who suspect they have been bitten by a tick carrying Lyme disease can purchase laboratory tests to aid in the identification of Lyme Disease. Individuals 18 years of age or older may access the test service at any of Quest’s 2,250 patient service centers across the United States without first needing to consult a physician. The service is available in 45 states starting today.